Does Glycine max leaves or Garcinia Cambogia promote weight-loss or lower plasma cholesterol in overweight individuals: a randomized control trial

Nutrition Journal

Myung-Sook Choi⁵  Robin A McGregor²  Tae-Sook Jeong³  Woo Song Lee¹  Ki Hun Park⁴  Seon-Min Jeon⁵  Ji-Eun Kim⁵ 

[1] Eco-Friendly Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup, Republic of Korea;Center for Food and Nutritional Genomics Research, Kyungpook National University, Daegu, Republic of Korea;National Research Laboratory of Lipid Metabolism & Atherosclerosis, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea;Division of Applied Life Science (BK 21 Program), EB-NCRC, Institute of Agriculture and Life Science, Graduate School of Gyeongsang National University, Jinju, Republic of Korea;Department of Food Science and Nutrition, Kyungpook National University, Daegu, Republic of Korea

关键词: weight-loss;    soybean leaves;    hydroxyl citric acid;    clinical trial;    cholesterol;    atherosclerosis;   

Others  :  828798
DOI  :  10.1186/1475-2891-10-94

 received in 2011-04-13, accepted in 2011-09-21,  发布年份 2011

【 摘 要 】

Background

Natural food supplements with high flavonoid content are often claimed to promote weight-loss and lower plasma cholesterol in animal studies, but human studies have been more equivocal. The aim of this study was firstly to determine the effectiveness of natural food supplements containing Glycine max leaves extract (EGML) or Garcinia cambogia extract (GCE) to promote weight-loss and lower plasma cholesterol. Secondly to examine whether these supplements have any beneficial effect on lipid, adipocytokine or antioxidant profiles.

Methods

Eighty-six overweight subjects (Male:Female = 46:40, age: 20~50 yr, BMI > 23 < 29) were randomly assigned to three groups and administered tablets containing EGML (2 g/day), GCE (2 g/day) or placebo (starch, 2 g/day) for 10 weeks. At baseline and after 10 weeks, body composition, plasma cholesterol and diet were assessed. Blood analysis was also conducted to examine plasma lipoproteins, triglycerides, adipocytokines and antioxidants.

Results

EGML and GCE supplementation failed to promote weight-loss or any clinically significant change in %body fat. The EGML group had lower total cholesterol after 10 weeks compared to the placebo group (p < 0.05). EGML and GCE had no effect on triglycerides, non-HDL-C, adipocytokines or antioxidants when compared to placebo supplementation. However, HDL-C was higher in the EGML group (p < 0.001) after 10 weeks compared to the placebo group.

Conclusions

Ten weeks of EGML or GCE supplementation did not promote weight-loss or lower total cholesterol in overweight individuals consuming their habitual diet. Although, EGML did increase plasma HDL-C levels which is associated with a lower risk of atherosclerosis.

【 授权许可】

   
2011 Kim et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW: Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999, 341:1097-1105.
• [2]Kopelman PG: Obesity as a medical problem. Nature 2000, 404:635-643.
• [3]Poobalan AS, Aucott LS, Smith WCS, Avenell A, Jung R, Broom J: Long-term weight loss effects on all cause mortality in overweight/obese populations. Obes Rev 2007, 8:503-513.
• [4]Grundy SM, Cleeman JI, Bairey Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ: Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004, 44:720-732.
• [5]Pittler MH, Ernst E: Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr 2004, 79:529-536.
• [6]Egras AM, Hamilton WR, Lenz TL, Monaghan MS: An evidence-based review of fat modifying supplemental weight loss products. J Obes 2011., 2011
• [7]Dewell A, Hollenbeck PLW, Hollenbeck CB: Clinical review: a critical evaluation of the role of soy protein and isoflavone supplementation in the control of plasma cholesterol concentrations. J Clin Endocrinol Metab 2006, 91:772-780.
• [8]Cederroth CR, Nef S: Soy, phytoestrogens and metabolism: A review. Mol Cell Endocrinol 2009, 304:30-42.
• [9]Messina M: Insights gained from 20 years of soy research. J Nutr 2010, 140:2289S-2295S.
• [10]Badimon L, Vilahur G, Padro T: Nutraceuticals and atherosclerosis: human trials. Cardiovasc Ther 2010, 28:202-215.
• [11]Cope MB, Erdman JW, Allison DB: The potential role of soyfoods in weight and adiposity reduction: an evidence-based review. Obes Rev 2008, 9:219-235.
• [12]Ho HM, Chen RY, Leung LK, Chan FL, Huang Y, Chen Z-Y: Difference in flavonoid and isoflavone profile between soybean and soy leaf. Biomed Pharmacother 2002, 56:289-295.
• [13]Yuk HJ, Lee JH, Curtis-Long MJ, Lee JW, Kim YS, Ryu HW, Park CG, Jeong T-S, Park KH: The most abundant polyphenol of soy leaves, coumestrol, displays potent [alpha]-glucosidase inhibitory activity. Food Chem 2011, 126:1057-1063.
• [14]Onakpoya I, Hung SK, Perry R, Wider B, Ernst E: The Use of Garcinia Extract (Hydroxycitric Acid) as a Weight loss Supplement: A Systematic Review and Meta-Analysis of Randomised Clinical Trials. J Obes 2011, 2011:509038.
• [15]Mattes RD, Bormann L: Effects of (-)-hydroxycitric acid on appetitive variables. Physiol Behav 2000, 71:87-94.
• [16]Ohia SE, Opere CA, LeDay AM, Bagchi M, Bagchi D, Stohs SJ: Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX). Mol Cell Biochem 2002, 238:89-103.
• [17]Roy S, Shah H, Rink C, Khanna S, Bagchi D, Bagchi M, Sen CK: Transcriptome of primary adipocytes from obese women in response to a novel hydroxycitric acid-based dietary supplement. DNA Cell Biol 2007, 26:627-639.
• [18]Kolodziejczyk J, Masullo M, Olas B, Piacente S, Wachowicz B: Effects of garcinol and guttiferone K isolated from Garcinia cambogia on oxidative/nitrative modifications in blood platelets and plasma. Platelets 2009, 20:487-492.
• [19]Amin KA, Kamel HH, Abd Eltawab MA: Protective effect of Garcinia against renal oxidative stress and biomarkers induced by high fat and sucrose diet. Lipids Health Dis 2011, 10:6. BioMed Central Full Text
• [20]Roongpisuthipong C, Kantawan R, Roongpisuthipong W: Reduction of adipose tissue and body weight: effect of water soluble calcium hydroxycitrate in Garcinia atroviridis on the short term treatment of obese women in Thailand. Asia Pac J Clin Nutr 2007, 16:25-29.
• [21]Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C: Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA 1998, 280:1596-1600.
• [22]WHO expert consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet 2004, 363:157-163.
• [23]Lukaski HC, Bolonchuk WW, Hall CB, Siders WA: Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 1986, 60:1327-1332.
• [24]Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gómez J, Lilienthal Heitmann B, Kent-Smith L, Melchior J-C, Pirlich M, Scharfetter H, M.W.J Schols A, Pichard C: Bioelectrical impedance analysis--part II: utilization in clinical practice. Clin Nutr 2004, 23:1430-1453.
• [25]Ard JD, Desmond RA, Allison DB, Conway JM: Dietary restraint and disinhibition do not affect accuracy of 24-hour recall in a multiethnic population. J Am Diet Assoc 2006, 106:434-437.
• [26]Hise ME, Sullivan DK, Jacobsen DJ, Johnson SL, Donnelly JE: Validation of energy intake measurements determined from observer-recorded food records and recall methods compared with the doubly labeled water method in overweight and obese individuals. Am J Clin Nutr 2002, 75:263-267.
• [27]Marklund S, Marklund G: Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974, 47:469-474.
• [28]Aebi H: Catalase. Bergmeyer, H. New York: Academic Press; 1986.
• [29]Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
• [30]Tarladgis BG, Pearson AM, Jun LRD: Chemistry of the 2-thiobarbituric acid test for determination of oxidative rancidity in foods. II.--formation of the tba-malonaldehyde complex without acid-heat treatment. J Sci Food Agric 1964, 15:602-607.
• [31]Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, Heitmann BL, Kent-Smith L, Melchior J-C, Pirlich M, Scharfetter H, Schols AMWJ, Pichard C: Bioelectrical impedance analysis--part I: review of principles and methods. Clin Nutr 2004, 23:1226-1243.
• [32]Kohno M, Hirotsuka M, Kito M, Matsuzawa Y: Decreases in serum triacylglycerol and visceral fat mediated by dietary soybean beta-conglycinin. J Atheroscler Thromb 2006, 13:247-255.
• [33]Lang V, Bellisle F, Alamowitch C, Craplet C, Bornet FR, Slama G, Guy-Grand B: Varying the protein source in mixed meal modifies glucose, insulin and glucagon kinetics in healthy men, has weak effects on subjective satiety and fails to affect food intake. Eur J Clin Nutr 1999, 53:959-965.
• [34]Jackson KA, Byrne NM, Magarey AM, Hills AP: Minimizing random error in dietary intakes assessed by 24-h recall, in overweight and obese adults. Eur J Clin Nutr 2008, 62:537-543.
• [35]Watts GF, Karpe F: Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient. Heart 2011, 97:350-356.
• [36]Vergeer M, Holleboom AG, Kastelein JJP, Kuivenhoven JA: The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? J Lipid Res 2010, 51:2058-2073.
• [37]Sacks FM: The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. Am J Cardiol 2002, 90:139-143.
• [38]Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S: The current state of serum biomarkers of hepatotoxicity. Toxicology 2008, 245:194-205.
• [39]Egert S, Rimbach G: Which Sources of Flavonoids: Complex Diets or Dietary Supplements? Adv Nutr 2011, 2:8-14.
• [40]Barbosa AC, Lajolo FM, Genovese MI: Effect of free or protein-associated soy isoflavones on the antioxidant status in rats. J Sci Food Agric 2011, 91:721-731.
• [41]Fritz KL, Seppanen CM, Kurzer MS, Saari Csallany A: The in vivo antioxidant activity of soybean isoflavones in human subjects. Nutr Res 2003, 23:479-487.
• [42]Jang J-H, Yoon J-Y, Cho S-H: Intake of dietary phytoestrogen and indices of antioxidant and bone metabolism of pre- and post-menopausal Korean women. Nutr Res Pract 2007, 1:305-312.
• [43]Rocha VZ, Libby P: Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009, 6:399-409.
• [44]Charles LE, Burchfiel CM, Violanti JM, Fekedulegn D, Slaven JE, Browne RW, Hartley TA, Andrew ME: Adiposity Measures and Oxidative Stress Among Police Officers. Obesity 2008, 16:2489-2497.
• [45]Zhuang X-F, Zhao M-M, Weng C-L, Sun N-L: Adipocytokines: a bridge connecting obesity and insulin resistance. Med Hypotheses 2009, 73:981-985.
• [46]Jones DY, Judd JT, Taylor PR, Campbell WS, Nair PP: Menstrual cycle effect on plasma lipids. Metabolism 1988, 37:1-2.
• [47]Lampe JW: Is equol the key to the efficacy of soy foods? Am J Clin Nutr 2009, 89:1664S-1667S.
• [48]Mortensen A, Kulling SE, Schwartz H, Rowland I, Ruefer CE, Rimbach G, Cassidy A, Magee P, Millar J, Hall WL, Kramer Birkved F, Sorensen IK, Sontag G: Analytical and compositional aspects of isoflavones in food and their biological effects. Mol Nutr Food Res 2009, 53:S266-309.
• [49]Loe YC, Bergeron N, Rodriguez N, Schwarz JM: Gas chromatography/mass spectrometry method to quantify blood hydroxycitrate concentration. Anal Biochem 2001, 292:148-154.
• [50]Bland JM, Altman DG: Regression towards the mean. BMJ 1994, 308:1499-1499.
• [51]Fadini GP: Nutraceutical antioxidants for vascular protection? Please mind regression toward the mean. Atherosclerosis 2011, 215:30-31.